Summit Securities Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,500
| Closed | -$366K | – | 737 |
|
|
2024
Q2 | $366K | Buy |
+22,500
| New | +$366K | 0.07% | 56 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 480 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 407 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 218 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 205 |
|
|
2016
Q1 | – | Sell |
-8,200
| Closed | -$538K | – | 334 |
|
|
2015
Q4 | $538K | Buy |
8,200
+2,900
| +55% | +$190K | 0.17% | 86 |
|
|
2015
Q3 | $299K | Buy |
5,300
+2,900
| +121% | +$164K | 0.22% | 55 |
|
|
2015
Q2 | $142K | Buy |
2,400
+100
| +4% | +$5.92K | 0.07% | 97 |
|
|
2015
Q1 | $143K | Sell |
2,300
-23,400
| -91% | -$1.45M | 0.11% | 93 |
|
|
2014
Q4 | $1.48M | Sell |
25,700
-13,100
| -34% | -$753K | 0.42% | 50 |
|
|
2014
Q3 | $2.09M | Buy |
38,800
+36,500
| +1,587% | +$1.96M | 0.6% | 44 |
|
|
2014
Q2 | $121K | Buy |
2,300
+1,800
| +360% | +$94.7K | 0.04% | 208 |
|
|
2014
Q1 | $26K | Sell |
500
-22,100
| -98% | -$1.15M | 0.02% | 210 |
|
|
2013
Q4 | $906K | Sell |
22,600
-10,800
| -32% | -$433K | 0.16% | 75 |
|
|
2013
Q3 | $1.26M | Buy |
33,400
+10,300
| +45% | +$389K | 0.43% | 37 |
|
|
2013
Q2 | $906K | Buy |
+23,100
| New | +$906K | 0.43% | 46 |
|